Manchester United and Chelsea accused of 'failing' Radamel Falcao by Monaco's vice-president
The Colombian only managed five goals in two seasons in the Premier League
Manchester United and Chelsea have been accused of failing Radamel Falcao during his loan spells at the clubs by Monaco’s vice-president Vadim Vasilyev.
The Colombian returns to London a year after he arrived at Chelsea and is looking to continue his good form in preseason during Wednesday’s Champions League clash with Tottenham.
Falcao was once considered one of the world’s most lethal strikers but two years in the Premier League with a return of only five goals has seen his stock fall.
And the blame for his decline has been laid directly at the feet of United and Chelsea, who, according to Vasilyev, were not patient enough with Falcao.
“Both clubs in England failed to relaunch him,” said Vasilyev.
“I don't know whether Manchester United and Chelsea did not have the patience or the desire to do that but I am quite sure this year we will see Falcao at his previous best.”
The 30-year-old suffered a severe ACL injury in 2014 and seemed to never really recover his goalscoring touch after his return, but Vasilyev insists he will get back to his best.
“He is the same Falcao as he ever,” he continued.
“We've seen that in pre-season. He scores goals, he's there and he is motivated, we are motivated and I think this will be his year.
“You have to be patient but the big clubs have other topics on their agenda. If you sign a player of this magnitude after a big injury it takes time and games to get him back into shape.
“This is what we will do and what Manchester United and Chelsea didn't do, failed to do or didn't want to do.
“We all see the qualities are there and it is a matter of time. Monaco will make every effort and you will see a very different Falcao this season to the one you saw in England.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies